Cirrhosis is a condition where the liver becomes permanently scarred, replacing healthy tissue with stiff, nonfunctional scar tissue that progressively blocks blood flow and impairs the organ’s ability to do its job. It develops over years or decades as the liver repeatedly tries to heal itself from ongoing damage. Globally, cirrhosis affects an estimated 58.4 million people, and it caused 1.43 million deaths in 2021 alone.
How Scar Tissue Replaces Healthy Liver
Every time the liver is injured, whether by alcohol, a virus, or fat buildup, it tries to repair itself. Part of that repair process involves specialized cells called hepatic stellate cells, which normally sit quietly in the liver. When triggered by damage, these cells transform into active, scar-producing cells that lay down tough, fibrous material (collagen and other structural proteins) in the liver tissue.
In small amounts, this scarring is manageable and can even reverse. But when the injury happens over and over for years, the scar tissue accumulates faster than the liver can clear it. The scarring stiffens the liver, distorts its internal structure, and chokes off the tiny blood vessels that liver cells depend on. Eventually, enough healthy tissue is replaced that the liver can no longer keep up with its hundreds of functions: filtering toxins, making proteins, producing bile, and regulating blood clotting.
Leading Causes
The single biggest driver of cirrhosis worldwide is now nonalcoholic fatty liver disease (NAFLD), which increased from 24.8 million cases in 1990 to 48.3 million in 2021. NAFLD develops when excess fat builds up in the liver, typically in people with obesity, type 2 diabetes, or metabolic syndrome. Many people with fatty liver have no idea they have it until the damage is advanced.
Long-term heavy alcohol use remains a major cause. Chronic hepatitis B and hepatitis C infections are also significant contributors, though effective antiviral treatments have begun reducing their impact in countries with good access to care. Less common causes include autoimmune hepatitis, bile duct diseases, genetic conditions like hemochromatosis (iron overload), and prolonged exposure to certain medications or toxins.
Symptoms in Early Versus Late Stages
Cirrhosis is often called a “silent” disease because the early stage, known as compensated cirrhosis, may produce no symptoms at all. Your liver has enough reserve capacity to keep functioning even with significant scarring. When early symptoms do appear, they tend to be vague: fatigue, mild weakness, poor appetite, unexplained weight loss, itchy skin, or a dull ache in the upper right abdomen. Muscle cramps, muscle loss, and sexual problems can also develop. Many people attribute these to aging or stress.
As the liver deteriorates further, it enters what doctors call decompensated cirrhosis. This is when the consequences become hard to ignore. Symptoms at this stage include:
- Jaundice: a yellowish tint to the skin and whites of the eyes, along with dark urine
- Ascites: swelling of the abdomen from fluid buildup
- Edema: swelling in the lower legs, ankles, and feet
- Easy bruising and bleeding: due to the liver’s failure to produce enough clotting proteins
- Confusion and memory problems: caused by toxins building up in the blood (hepatic encephalopathy)
- Internal bleeding: from swollen veins in the esophagus or stomach that can rupture
How Cirrhosis Affects the Brain
One of the more alarming complications is hepatic encephalopathy, a condition where toxins that the liver would normally filter, especially ammonia, accumulate in the bloodstream and reach the brain. Ammonia disrupts brain cells called astrocytes, causing them to swell. It also interferes with the energy supply inside brain cells by impairing their mitochondria.
The symptoms range widely. In mild cases, you might notice subtle changes: difficulty concentrating, forgetfulness, a reversed sleep cycle where you’re awake at night and drowsy during the day, or a flattened emotional affect. In more severe cases, encephalopathy can progress to visible hand tremors, significant confusion, personality changes, and eventually stupor or coma. Systemic inflammation in the body worsens the effect of ammonia, creating a compounding cycle that makes this complication unpredictable.
Portal Hypertension and Fluid Buildup
Scar tissue in the liver creates a traffic jam for blood trying to flow through it. The portal vein, which carries blood from the intestines to the liver, backs up under increasing pressure. This is called portal hypertension, and it triggers a cascade of problems throughout the body.
The backed-up blood forces the body to reroute through smaller, weaker veins in the esophagus and stomach. These veins, called varices, were never designed to handle that volume. They can swell dangerously and rupture, causing life-threatening internal bleeding. Portal hypertension also activates hormonal systems that cause the body to retain salt and water, which leads to ascites (the fluid accumulation in the abdomen that can make a person look visibly pregnant) and swelling in the legs.
How Cirrhosis Is Diagnosed
Liver biopsy, where a small needle removes a tissue sample for examination under a microscope, has long been the gold standard for confirming cirrhosis and grading the severity of scarring. But it’s invasive and carries a small risk of complications, so noninvasive alternatives have become increasingly common.
Transient elastography (often known by the brand name FibroScan) uses sound waves to measure liver stiffness, which correlates with the degree of scarring. For detecting cirrhosis specifically, the test has a sensitivity of 77% and a specificity of 97%, meaning it’s very good at ruling cirrhosis out and reasonably good at confirming it. A liver stiffness value above 17.6 kilopascals strongly suggests cirrhosis. Blood tests measuring liver enzymes, bilirubin, albumin, and clotting times provide additional clues, and imaging like ultrasound can reveal physical changes in the liver’s shape and texture.
Once cirrhosis is confirmed, doctors assess its severity using a scoring system that looks at five factors: bilirubin levels, albumin levels, how well the blood clots, whether ascites is present, and whether there are signs of encephalopathy. Each factor earns points, and the total places you in one of three categories. Class A indicates relatively well-preserved liver function. Class B signals significant compromise. Class C represents severe, advanced disease. This classification guides treatment decisions, including whether a liver transplant evaluation is appropriate.
Survival and Prognosis
The difference between compensated and decompensated cirrhosis is stark when it comes to life expectancy. In a long-term study tracking patients over many years, people with compensated cirrhosis had a median survival of about 10 years. Those who had progressed to decompensated cirrhosis had a median survival of roughly 4.5 years, less than half. The transition from compensated to decompensated is the critical turning point.
What triggers decompensation varies. Continued alcohol use, an untreated viral infection, or the development of a new complication like a bacterial infection can push a stable liver over the edge. This is why identifying and treating the underlying cause early matters so much.
Can Cirrhosis Be Reversed?
For years, cirrhosis was considered irreversible. That view has shifted. Multiple studies now show that fibrosis, and in some cases even early cirrhosis, can regress if the underlying cause is eliminated and the liver is given time to heal. Early-stage scarring that hasn’t yet developed extensive cross-linking between collagen fibers has the best chance of reverting toward normal architecture.
The evidence is strongest for viral hepatitis. In one study of hepatitis B patients treated with the antiviral tenofovir for five years, 74% improved enough on biopsy that they were no longer classified as cirrhotic. A study using another antiviral, lamivudine, showed reversal of cirrhosis in 73% of treated patients. For hepatitis C, 82% of patients who achieved a sustained viral cure after treatment showed decreased scarring on five-year follow-up biopsies.
For alcohol-related cirrhosis, abstinence is the most powerful intervention. A study of 100 patients with alcoholic cirrhosis found that those who stopped drinking within a month of diagnosis had significantly better long-term survival, though direct biopsy evidence of fibrosis reversal in this group is more limited. For fatty liver disease, weight loss, improved metabolic health, and certain medications have shown the ability to reduce scarring in clinical trials, though results are more modest.
The takeaway: advanced cirrhosis with extensive scarring and complications is unlikely to fully reverse. But catching it earlier and aggressively treating the cause gives the liver a real chance to recover, at least partially.
Living With Cirrhosis
Managing cirrhosis centers on two goals: slowing further damage and preventing complications. If alcohol is involved, complete abstinence is essential. If a virus is the cause, antiviral treatment is a priority. For fatty liver disease, gradual weight loss and control of diabetes or metabolic conditions form the foundation.
Diet plays a practical role. Sodium restriction to under 2,000 milligrams per day (less than a teaspoon of salt) helps control fluid retention and ascites. Protein is not restricted, contrary to older advice, but should be consumed in moderate, consistent amounts to support muscle mass without overloading the liver. Small, frequent meals are easier to tolerate than large ones, especially for people experiencing nausea or early fullness.
Screening for complications becomes part of routine care. This includes periodic upper endoscopy to check for varices in the esophagus, regular imaging to monitor for liver cancer (which cirrhosis increases the risk of), and blood work to track liver function over time. For people whose liver function continues to decline despite treatment, liver transplant evaluation becomes a consideration. Transplant outcomes have improved significantly, and for the right candidates, it offers the possibility of a full recovery.